Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Multi Center Study Study of the Effects of Selective Retinal Photocoagulation for the Treatment of Diabetic Macular Edema

NCT01355692 is registered in ClinicalTrials.gov with Lumenis Be Ltd. as lead sponsor.

NCT NCT01355692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01355692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Multi Center Study Study of the Effects of Selective Retinal Photocoagulation for the Treatment of Diabetic Macular Edema
Lead sponsor
Lumenis Be Ltd.
Phase
Phase 2/3
Overall status
Completed
Start date
December 31, 2009
Completion date
July 31, 2015
Enrollment
32 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema